In recent years, increasing evidence demonstrates a substantial influence of HDACs on glucose and lipid metabolism, potentially qualifying pharmacological modulation of HDAC activity as an approach to counteract metabolic disorders including obesity and type 2 diabetes. Here, HDAC9 is linked to Other metabolic disease.